Zyga Technologies closes a $10 million equity and stock funding round in support of its spinal treatment devices.
Minnesota-based Zyga Technologies closed a $10 million funding round with the help of 5 unnamed investors, according to regulatory filings.
The spinal devices maker raised the money through sales of equity and Series C-2 preferred stock, closing the round just 10 days after marking the 1st sale.